↓ Skip to main content

Open‐label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients

Overview of attention for article published in Clinical and Translational Allergy, May 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
5 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Open‐label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
Published in
Clinical and Translational Allergy, May 2013
DOI 10.1186/2045-7022-3-16
Pubmed ID
Authors

Juliane Rieker-Schwienbacher, Marja J Nell, Zuzana Diamant, Ronald van Ree, Andreas Distler, Johan D Boot, Jörg Kleine-Tebbe

Abstract

The current maintenance dose (10,000 AUeq/monthly) of a subcutaneous allergoid for house dust mite (HDM) immunotherapy has previously shown significant clinical efficacy in patients with HDM induced allergic rhinitis or rhinoconjunctivitis. In order to comply with the 2009 EMA guidelines on immunotherapy products, a study was conducted to evaluate the safety, tolerability and short-term treatment effects of up-dosing regimens with high doses (up to 40,000 AUeq) of allergoid HDM immunotherapy.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 22%
Professor > Associate Professor 3 17%
Lecturer 2 11%
Student > Doctoral Student 1 6%
Professor 1 6%
Other 1 6%
Unknown 6 33%
Readers by discipline Count As %
Medicine and Dentistry 7 39%
Arts and Humanities 1 6%
Physics and Astronomy 1 6%
Immunology and Microbiology 1 6%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2013.
All research outputs
#16,722,190
of 25,374,917 outputs
Outputs from Clinical and Translational Allergy
#577
of 756 outputs
Outputs of similar age
#125,527
of 205,445 outputs
Outputs of similar age from Clinical and Translational Allergy
#10
of 14 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 756 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 205,445 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.